← Back to Search

Visual Feedback Goggles for Positional Vertigo

Phase 1 & 2
Waitlist Available
Led By Philip F Anthony, MD
Research Sponsored by Vertigone Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age: 30-80
Must have good neck flexibility to perform the movements of the Epley maneuver
Must not have
Not willing to remain in the clinic for the treatment and follow-up visits
Cannot perform the movements of the Epley maneuver
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years

Summary

This trial is a prospective, single-center, interventional study of the VertiGONE goggle in the treatment of BPPV. The study will enroll 100 subjects who will be randomized to either the VertiGONE goggle group or the control group. The primary outcome measure will be the resolution of vertigo, as measured by the Dizziness Handicap Inventory (DHI).

Who is the study for?
This trial is for people aged 30-80 with Benign Paroxysmal Positional Vertigo (BPPV), who have had symptoms for at least 3 months. Participants must be able to give informed consent, stay in the clinic for treatment and follow-ups, and have good neck flexibility to perform specific head movements.
What is being tested?
The study tests two versions of a goggle that provides visual feedback during the Epley maneuver—a technique used to treat BPPV by repositioning particles in the inner ear. The goal is to see if better accuracy improves vertigo resolution.
What are the potential side effects?
Since this trial involves non-invasive goggles designed to guide a physical maneuver without medication, side effects are minimal but may include temporary dizziness or discomfort from performing the Epley maneuver.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 30 and 80 years old.
Select...
I can move my neck freely to perform specific head movements.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am not willing to stay in the clinic for treatment and follow-ups.
Select...
I cannot do the Epley maneuver.
Select...
I am younger than 30 or older than 80.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: 1 Goggle IExperimental Treatment1 Intervention
Optimized Goggle
Group II: 2 Google IIPlacebo Group1 Intervention
Goggle with 20 Degree error

Find a Location

Who is running the clinical trial?

Vertigone Inc.Lead Sponsor
Philip F Anthony, MDPrincipal InvestigatorVertigone Inc.

Media Library

Visual Feedback Goggle Clinical Trial Eligibility Overview. Trial Name: NCT00729885 — Phase 1 & 2
Migrainous Vertigo Research Study Groups: 1 Goggle I, 2 Google II
Migrainous Vertigo Clinical Trial 2023: Visual Feedback Goggle Highlights & Side Effects. Trial Name: NCT00729885 — Phase 1 & 2
Visual Feedback Goggle 2023 Treatment Timeline for Medical Study. Trial Name: NCT00729885 — Phase 1 & 2
~3 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top